<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJU</journal-id><journal-title-group><journal-title>Open Journal of Urology</journal-title></journal-title-group><issn pub-type="epub">2160-5440</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oju.2024.142013</article-id><article-id pub-id-type="publisher-id">OJU-131547</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Epidemiologic, Diagnostic, and Therapeutic Features of Urinary Stone Disease in Northern Benin from 2018 to 2023
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gandaho</surname><given-names>Isidore</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sossa</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Toré</surname><given-names>Sanni Rafiou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dènon</surname><given-names>Emmanuel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Allodé</surname><given-names>Alexandre</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Avakoudjo</surname><given-names>Déjinnin Josué Georges</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Département de Chirurgie et Spécialités Chirurgicales, Université de Parakou, Parakou, Bénin</addr-line></aff><aff id="aff2"><addr-line>Faculté des Sciences de la Santé, Université d’Abomey-Calavi, Abomey-Calavi, Bénin</addr-line></aff><pub-date pub-type="epub"><day>04</day><month>02</month><year>2024</year></pub-date><volume>14</volume><issue>02</issue><fpage>128</fpage><lpage>137</lpage><history><date date-type="received"><day>14,</day>	<month>January</month>	<year>2024</year></date><date date-type="rev-recd"><day>26,</day>	<month>February</month>	<year>2024</year>	</date><date date-type="accepted"><day>29,</day>	<month>February</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: To determine the epidemiologic, diagnostic, and therapeutic features of urinary in northern Benin from 2018 to 2023. 
  Patients and Method: The study was an observational and descriptive one. We exhaustively and retrospectively collected data from the medical records of the patients that were managed from February 1, 2018 to February 1, 2023 at the Department of Surgery of “Centre Hospitalier Universitaire D&#233;partmental Borgou-Alibori or CHUD-BA”. 
  Results: Among the 4522 patients managed, 75% or 1.7% had urinary stone disease. Their mean age was 41 years. The sex ratio was 2.75, the males being predominantly affected. Of the 75 cases of urinary stone disease, 30.7% (n = 23) were renal, 46.7% (n = 35) were ureteral, and 22.7% (n = 17) were vesical. The patients came from variable geographical areas, ethnic groups, and professional sectors. Their main complaints were pain (57.3%), hematuria (14.7%), dysuria (12%), and fever (5.3%). 15 (20%) patients, 
  <em>i.e.</em>, 7 renal stone and 8 ureteral stone patients, had an obstructive renal failure. The imaging tools available were ultrasonography, tomography and computed tomographic scan. 11 of the bladder stone cases (64.7%) were associated with a bladder outlet obstruction. Overall, 38.7% of the patients had either diabetes mellitus (6.7%), hypertension or high blood pressure (6.7%), benign prostate hyperplasia (8%), urinary schistosomiasis (6.7%), ureteral pelvic junction obstruction (2.7%), and prostate cancer (1.3%). Of the 19 patients whose dietary behavior was investigated 15 (79%), 11 (57.9%) et 11 (57.9%) demonstrated a diet which was respectively rich in milk, fromage and meat. 100% of bladder stones were removed through cystolithotomy. Renal stones were removed by pyelolithtomy (52.2%) and nephrolithotomy (21.7%). Ureteral stones were removed through ureterolithotomy (40%), expelled by means of alpha-blockers (40%) or managed with ureteral pigtail stent (20%). 
  Conclusion: The hospital prevalence of urinary stone disease was 1.7%. The mean age in urinary stone-affected patients was 41 years. The urinary stone predominantly affected male patients: the sex ratio was 2.75. The stones were mainly removed through open surgery.
 
</p></abstract><kwd-group><kwd>Urinary Stone</kwd><kwd> Epidemiologic</kwd><kwd> Diagnostic</kwd><kwd> Therapeutic</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Urinary stone disease results from an abnormal crystallization of urine components in the urinary tract [<xref ref-type="bibr" rid="scirp.131547-ref1">1</xref>] . That disease is more frequent in patients above the age of 60 years [<xref ref-type="bibr" rid="scirp.131547-ref2">2</xref>] . Still, it is more and more affecting younger populations [<xref ref-type="bibr" rid="scirp.131547-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref4">4</xref>] . Its incidence is variable: 7% to 13% in northern America, 5% to 9% in Europe, and 1% to 5% in Asia [<xref ref-type="bibr" rid="scirp.131547-ref5">5</xref>] . In Burkina Faso, the prevalence of urinary stone disease is 12.5% [<xref ref-type="bibr" rid="scirp.131547-ref6">6</xref>] . Obesity, diet modifications, and climate changes make urinary stone disease increase in the world [<xref ref-type="bibr" rid="scirp.131547-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref9">9</xref>] .</p><p>Computed tomography has dramatically bettered the diagnosis of urinary stone [<xref ref-type="bibr" rid="scirp.131547-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref12">12</xref>] which treatment is turning mini-invasive by using extracorporeal shock wave lithotripsy, percutaneous nephrolithotomy, ureteroscopy, and cystolitholapaxy [<xref ref-type="bibr" rid="scirp.131547-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref14">14</xref>] .</p><p>Still, open surgery remains the main stone treatment modality in Benin and other developing countries.</p><p>Studies on urinary stone disease have been performed in Benin, [<xref ref-type="bibr" rid="scirp.131547-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref16">16</xref>] but its overall status has not yet been evaluated.</p></sec><sec id="s2"><title>2. Objective</title><p>This study aims to determine epidemiologic, diagnostic, and therapeutic features of urinary stone disease in northern Benin from 2018 to 2023.</p></sec><sec id="s3"><title>3. Patients et Methode</title><p>We performed an observational and descriptive study. We retrospectively collected urinary stone data from medical records of patients managed from February 1, 2018, to February 1, 2013, in the Surgical Department of the “Centre Hospitalier Universitaire D&#233;partmental Borgou Alibori or CHUD-BA”. The CHUD-BA is the university teaching hospital in Parakou, the biggest town in northern Benin. We made an exhaustive census of patients and systematically collected data from their medical records. Were included patients with imaging-confirmed urinary stones. Were excluded, urinary stone patients with no confirmatory imaging or incomplete medical record.</p><p>Data collected were age, gender, ethnicity, provenance, profession, marital status, dietary behavior, symptoms, history, type of imaging, stone location, type of treatment, treatment outcome.</p><p>Collected data were analyzed with Excel&#174; 2019 and EPI Info 7.2. The means and the proportions were used to describe respectively the quantitative and qualitative variables.</p></sec><sec id="s4"><title>4. Results</title><p>4522 patients were managed in the Department of Surgery. 75 of them were urinary stone-affected, which yielded a hospital prevalence of 1.7%. Their age ranged from 9 to 80 years. Their mean age was 41 years (standard deviation = 3.98). Eight patients (10.7%) including 7 males and 1 female, were less than 20 years old. Among the 75 urinary stone-affected patients, there were 55 males (73.3%) et 20 females (26.7%). The sex ratio was 2.75.</p><p><xref ref-type="table" rid="table1">Table 1</xref> presents the patients’ profession, provenance, and ethnicity. Regarding the profession there were 20% public service officers, 14.7% craftsmen, 13.3% traders, and 9.3% students. Most of the patients, i.e., 72%, came from Borgou, the geographical area sheltering the CHUD-BA hospital. The most frequent ethnic groups were the Fon (32%) and the Batonu (21.3%).</p><p>Stone locations and main symptoms in the patients are presented on <xref ref-type="table" rid="table2">Table 2</xref>. There were 23 (30.7%) renal, 35 (46.7%) ureteral, and 17 (22.7%) vesical stones. 43 patients (57.3%) complained about pain which was either lumbar (52%), iliac (4%), or pelvic (1.3%). 11 (14.7%), 9 (12%) et 4 (5.3%) patients had respectively a hematuria, a dysuria, and a fever. The stones’ size ranged from 1 to 30 mm. Yet the main complaint varied according to the stone’s location.</p><p>18 in the 23 patients with renal stone experienced pain as lumbar pain (47.8%) or renal colic (30.4%). The symptoms in the others were dysuria, hematuria,</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Number of patients according to the profession, provenance, and ethnicity (n = 75)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Profession</th><th align="center" valign="middle"  colspan="2"  >Provenance</th><th align="center" valign="middle"  colspan="2"  >Ethnicity</th></tr></thead><tr><td align="center" valign="middle" >Designation</td><td align="center" valign="middle" >Number (%)</td><td align="center" valign="middle" >Designation</td><td align="center" valign="middle" >Number (%)</td><td align="center" valign="middle" >Designation</td><td align="center" valign="middle" >Number (%)</td></tr><tr><td align="center" valign="middle" >Public servants</td><td align="center" valign="middle" >15 (20)</td><td align="center" valign="middle" >Borgou</td><td align="center" valign="middle" >54 (72)</td><td align="center" valign="middle" >Fon</td><td align="center" valign="middle" >24 (32)</td></tr><tr><td align="center" valign="middle" >Unemployed</td><td align="center" valign="middle" >15 (20)</td><td align="center" valign="middle" >Donga</td><td align="center" valign="middle" >6 (8)</td><td align="center" valign="middle" >Batonu</td><td align="center" valign="middle" >16 (21.3)</td></tr><tr><td align="center" valign="middle" >Crafts men</td><td align="center" valign="middle" >11 (14.7)</td><td align="center" valign="middle" >Alibori</td><td align="center" valign="middle" >3 (4)</td><td align="center" valign="middle" >Dendi</td><td align="center" valign="middle" >11 (14.7)</td></tr><tr><td align="center" valign="middle" >Traders</td><td align="center" valign="middle" >10 (13.3)</td><td align="center" valign="middle" >Atacora</td><td align="center" valign="middle" >3 (4)</td><td align="center" valign="middle" >Nago</td><td align="center" valign="middle" >7 (9.3)</td></tr><tr><td align="center" valign="middle" >Students/pupils</td><td align="center" valign="middle" >7 (9.3)</td><td align="center" valign="middle" >Collines</td><td align="center" valign="middle" >2 (2.7)</td><td align="center" valign="middle" >Lokpa</td><td align="center" valign="middle" >3 (4)</td></tr><tr><td align="center" valign="middle" >Retired</td><td align="center" valign="middle" >1 (1.3)</td><td align="center" valign="middle" >Littoral</td><td align="center" valign="middle" >1 (1.3)</td><td align="center" valign="middle" >Otamari</td><td align="center" valign="middle" >2 (2.7)</td></tr><tr><td align="center" valign="middle" >Non specified</td><td align="center" valign="middle" >16 (21.3)</td><td align="center" valign="middle" >Nigeria</td><td align="center" valign="middle" >1 (1.3)</td><td align="center" valign="middle" >Adja</td><td align="center" valign="middle" >1 (1.3)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >75 (100)</td><td align="center" valign="middle" >Unspecified</td><td align="center" valign="middle" >5 (6.7)</td><td align="center" valign="middle" >Peulh</td><td align="center" valign="middle" >1 (1.3)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >75 (100)</td><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >1 (1.3)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >75 (100)</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Complaints and location of urinary stones (n = 75)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Complaints</th><th align="center" valign="middle"  colspan="6"  >Location of urinary stones</th><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Total (N = 75)</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Kidney (n = 23)</td><td align="center" valign="middle"  colspan="2"  >Ureter (n = 35)</td><td align="center" valign="middle"  colspan="2"  >Bladder (n = 17)</td></tr><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Lumbar pain</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >47.8</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8.6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >18.7</td></tr><tr><td align="center" valign="middle" >Renal colic</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >30.4</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >51.4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >33.3</td></tr><tr><td align="center" valign="middle" >Iliac pain</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8.6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4.0</td></tr><tr><td align="center" valign="middle" >Pelvic pain</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.3</td></tr><tr><td align="center" valign="middle" >Painful micturition</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.9</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.7</td></tr><tr><td align="center" valign="middle" >Dysuria</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >47.1</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >12.0</td></tr><tr><td align="center" valign="middle" >Hematuria</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >13.0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8.6</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >29.4</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >14.7</td></tr><tr><td align="center" valign="middle" >Pollakiuria</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.9</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.7</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.3</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8.6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >5.3</td></tr><tr><td align="center" valign="middle" >Incidental</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.3</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.7</td></tr><tr><td align="center" valign="middle" >CBRU*</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.9</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.3</td></tr><tr><td align="center" valign="middle" >Pyuria</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >5.9</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.3</td></tr></tbody></table></table-wrap><p>*CBRU = Complete Bladder Retention of Urine.</p><p>pollakiuria and painful micturition.</p><p>Among 35 patients with ureteral stone, 25 patients (71.4%) had a pain which was lumbar (60%), iliac (8.6%), and pelvic (2.9%). The pain was a renal colic type in 18 cases (51.4%) of ureteral stones. The other main complaints in ureteral stones patients were hematuria (14.7%), dysuria (12.0%), and fever (5.3%).</p><p>Of the 17 cases of bladder stones, 8 (47.1%), 5 (29.4%), 1 (5.9%), 1 (5.9%), 1 (5.9%) et 1 (5.9%) were respectively revealed by dysuria, hematuria, pollakiuria, painful micturition, complete bladder urinary retention and pyuria. 11 in the 17 bladder stone patients, i.e., 64.7% had a bladder outlet obstructing disease: benign prostate hyperplasia (7 cases, i.e., 41.2%), urinary schistosomiasis (3 cases, i.e., 17.6%), prostate cancer (1 case, i.e., 5.9%).</p><p><xref ref-type="table" rid="table3">Table 3</xref> presents disease and dietary history in the stone-affected patients. 38.7% patients had some disease history: diabetes mellitus (6.7%), high blood pressure (6.7%), benign prostate hyperplasia (8%), urinary schistosomiasis (6.7%), ureteropelvic junction obstruction (2.7%), prostate cancer (1.3%). Dietary behavior was evaluated in 19 patients (25.3%). The diet in all 19 patients was rich in dairy products. 16 (84.2%), 10 (52.6%) et 6 (31.6%) of those 19 patients had respectively a diet rich in animal proteins (i.e., meat, fish), hot drinks (i.e., coffee, tea), and green vegetables (cabbage).</p><p>Imaging tools utilized to diagnose the stones were ultrasonography of the urinary system (69.3%), kidneys-ureters-bladder (KUB) non-contrast enhanced tomography (2.7%) and computed tomographic urography (37.3%). There were 1 to 2 stones in the upper urinary tract (kidney, ureter) and 1 to 10 stones in the bladder. The stones size ranged from 1 to 30 mm.</p><p>Stone diagnostic imaging in 14 (60.9%), 8 (34.7%), and 1 (4.3%) patients were respectively ultrasonography, computed tomographic urography and KUB tomography. 6 patients (26.1%) had a calyceal stones, 5 patients (21.7%) had pelvic stones; intrarenal stone location was not specified in the other patients. Kidney stones were unilateral and obstructive in 60.9% of the patients, bilateral and obstructive with renal failure in 30.4% of the patients (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>For the diagnosis of ureteral stones, KUB tomography with or without ultrasonography and computed tomography were used respectively in 18 (51.4%) and 17 (48.6%) patients. Ureteral stone was bilateral and obstructive in 22.9% cases, unilateral and obstructive in 40% cases, unilateral and non-obstructive in 37.1% cases (<xref ref-type="table" rid="table4">Table 4</xref>). Among 40 affected ureteral units the stone location was lumbar, iliac, pelvic, and intramural respectively in 25% (n = 10), 5% (n = 2), 32.5% (n =</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Dietary behavior and disease history of the patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Dietary behavior (n = 19)</th><th align="center" valign="middle"  colspan="2"  >Disease history (n = 29, % = 38.7)</th></tr></thead><tr><td align="center" valign="middle" >Foods</td><td align="center" valign="middle" >Number (%)</td><td align="center" valign="middle" >Diseases</td><td align="center" valign="middle" >Number (%)</td></tr><tr><td align="center" valign="middle" >Milk</td><td align="center" valign="middle" >15 (79)</td><td align="center" valign="middle" >Diabetes mellitus</td><td align="center" valign="middle" >5 (6.7)</td></tr><tr><td align="center" valign="middle" >Cheese</td><td align="center" valign="middle" >11 (57.9)</td><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >5 (6.7)</td></tr><tr><td align="center" valign="middle" >Meat</td><td align="center" valign="middle" >11 (57.9)</td><td align="center" valign="middle" >Renal colic</td><td align="center" valign="middle" >4 (5.3)</td></tr><tr><td align="center" valign="middle" >Fish</td><td align="center" valign="middle" >5 (26.3)</td><td align="center" valign="middle" >BPH</td><td align="center" valign="middle" >6 (8.0)</td></tr><tr><td align="center" valign="middle" >Cabbage</td><td align="center" valign="middle" >6 (31.6)</td><td align="center" valign="middle" >Urinary schistosomiasis</td><td align="center" valign="middle" >5 (6.7)</td></tr><tr><td align="center" valign="middle" >Coffee</td><td align="center" valign="middle" >6 (31.6)</td><td align="center" valign="middle" >Urinary surgery</td><td align="center" valign="middle" >3 (4.0)</td></tr><tr><td align="center" valign="middle" >Tea</td><td align="center" valign="middle" >4 (21.1)</td><td align="center" valign="middle" >UPJO</td><td align="center" valign="middle" >2 (2.7)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Urinary lithiasis</td><td align="center" valign="middle" >2 (2.7)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Urinary infection</td><td align="center" valign="middle" >1 (1.3)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Prostate cancer</td><td align="center" valign="middle" >1 (1.3)</td></tr></tbody></table></table-wrap><p>BPH = Benign Prostate Hyperplasia – UPJO = Uretero-Pelvic Junction Obstruction.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Characteristics of renal and ureteral lithiasis</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Characteristics</th><th align="center" valign="middle"  colspan="2"  >Stone location</th></tr></thead><tr><td align="center" valign="middle" >Kidney (n et % patients)</td><td align="center" valign="middle" >Ureter (n et % patients)</td></tr><tr><td align="center" valign="middle" >Unilateral and obstructive</td><td align="center" valign="middle" >14 (60.9)</td><td align="center" valign="middle" >14 (40)</td></tr><tr><td align="center" valign="middle" >Unilateral and non-obstructive</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >13 (37.1)</td></tr><tr><td align="center" valign="middle" >Bilateral and obstructive</td><td align="center" valign="middle" >7 (30.4)</td><td align="center" valign="middle" >8 (22.9)</td></tr><tr><td align="center" valign="middle" >Bilateral and non-obstructive</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Non specified</td><td align="center" valign="middle" >2 (8.7)</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Total number of patients</td><td align="center" valign="middle" >23 (100)</td><td align="center" valign="middle" >35 (100)</td></tr></tbody></table></table-wrap><p>13) et 15% (n = 6) cases. The stone’s segmentary location was not indicated in 9 patients (22.5%).</p><p>The stone’s treatment varied according to its location. Renal stones were treated by pyelolithotomy in 12 patients (52.2%), nephrolithotomy in 5 patients (21.7%), ureteral pigtail stent in 1 patient (4.3%). Ureteral stones were treated by alpha-blockers in 14 patients (40%), ureterolithotomy in other 14 patients (40%), and ureteral pigtail stent in 7 patients (20%). Each one of the 17 cases of bladder stone was treated by cystolithotomy.</p><p>Overall, 47 patients in 75 had received a medical therapy: alpha-blocker (29 cases, i.e., 38.7%), non-steroidal anti-inflammatory drug (24 cases, i.e., 32%), antispasmodic (2 cases, i.e., 2.7%). The use of alpha-blocker aimed the medical expulsion of ureteral stone, but data were not available on the achieved rate of stone’s expulsion.</p></sec><sec id="s5"><title>5. Discussion</title><p>The hospital prevalence of stone disease was 1.7% in CHUD-BA i.e., nearly half that of 3.7% computed at Cotonou in 2015 [<xref ref-type="bibr" rid="scirp.131547-ref16">16</xref>] . The difference may be linked to the fact that life standards are higher and the tendency to higher consumption of animal protein and dairy products in southern than in northern Benin. Besides, the climate is hot and humid in the south while it is hot and dry in the north: body hydration challenges are discrepant between the two regions.</p><p>The mean age was 41 years. It is similar to 39.6 ans [<xref ref-type="bibr" rid="scirp.131547-ref16">16</xref>] , 47 ans [<xref ref-type="bibr" rid="scirp.131547-ref9">9</xref>] , and 40.5 ans [<xref ref-type="bibr" rid="scirp.131547-ref17">17</xref>] found in other regional studies.</p><p>10.7% patients (7 males and 1 female) were less than 20 years old. Urinary stone disease is rare in childhood and adolescence where it is often associated with obstructive malformations of the urinary tract or genetic anomalies [<xref ref-type="bibr" rid="scirp.131547-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref20">20</xref>] .</p><p>We observed a masculine predominance among the stone-affected patients. The sex ratio was 2.75. Several studies have demonstrated the masculine predominance in urinary stone disease with variable sex-ratio: 2 [<xref ref-type="bibr" rid="scirp.131547-ref21">21</xref>] , 1.4 [<xref ref-type="bibr" rid="scirp.131547-ref22">22</xref>] and 1.61 [<xref ref-type="bibr" rid="scirp.131547-ref23">23</xref>] . The masculine predominance may be linked to the higher tendency to urinary tract obstruction in aging males or the estrogens’ promoting effect on urine citrate’s stone formation inhibiting activities [<xref ref-type="bibr" rid="scirp.131547-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref25">25</xref>] .</p><p>Most of the patients (72%) came from Borgou, the geographical area that sheltered the CHUD-BA. The remaining patients came from other neighboring areas with no urologist. The patients belonged to several ethnic and professional groups. Some professions such as craftsmen and agriculturalists which necessitate physical activity do contribute to body dehydration. Still, none of the patients were agriculturalists or herders despite the region was one of high animal and agricultural production activity. Some authors have founded that stone-affected patients were agriculturalists and students [<xref ref-type="bibr" rid="scirp.131547-ref26">26</xref>] .</p><p>An obstructive uropathy was present in 18.7% of the patients: benign prostate hyperplasia (8%, n = 6), urinary schistosomiasis (6.7%, n = 5), ureteropelvic junction obstruction (2.7%, n = 2), prostate cancer (1.3%, n = 1) [<xref ref-type="bibr" rid="scirp.131547-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref27">27</xref>] . In several studies, benign prostate hyperplasia is the main urological disease associated with urinary lithiasis. According to Bah et al. [<xref ref-type="bibr" rid="scirp.131547-ref26">26</xref>] , benign prostate hyperplasia (42.2%) and urethral stenosis are the main obstructive causes of urinary stone disease. Urological tumors especially prostate tumors are associated with urinary lithiasis in 31.4% cases [<xref ref-type="bibr" rid="scirp.131547-ref28">28</xref>] . 31.4% and 60.5% urinary stones cases are respectively associated with urological tumors, mainly prostate tumors [<xref ref-type="bibr" rid="scirp.131547-ref28">28</xref>] , and with urogenital schistosomiasis [<xref ref-type="bibr" rid="scirp.131547-ref29">29</xref>] .</p><p>Stone disease in our patients was diagnosed with ultrasonography (69.3%) and computed tomography (37.3%). Nowadays, non-contrast enhanced computed tomography of abdomen and pelvis is the gold standard imaging tool for the diagnosis of urinary stone. An alternative tool is the ultrasonography combined with KUB non-contrast enhanced tomography [<xref ref-type="bibr" rid="scirp.131547-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref25">25</xref>] . The situation in CHUD-BA is similar to that in most of the sub-regional care units [<xref ref-type="bibr" rid="scirp.131547-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref30">30</xref>] . Often patients cannot afford the cost of computed tomography which limits its usage.</p><p>46.7%, 30.7% et 22.7% of the stones were respectively ureteral, renal, and vesical. In two other studies, there were 54.3% and 43.5% renal stones, 34.1% and 39.1% ureteral stones, 11.5% and 17.4% bladder stones [<xref ref-type="bibr" rid="scirp.131547-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref30">30</xref>] .</p><p>57.3% of the urinary stones were revealed by pain, 33.3% cases of which was a renal colic. Renal colic was present in 51.4% ureteral stones versus 30.4% renal stones. The pain is the main symptom according to several studies. Diallo et al. [<xref ref-type="bibr" rid="scirp.131547-ref9">9</xref>] have reported 94.9% pain, 28.8% of which being a renal colic. Renal colic reveals 67.5% [<xref ref-type="bibr" rid="scirp.131547-ref17">17</xref>] and 79.4% [<xref ref-type="bibr" rid="scirp.131547-ref16">16</xref>] of ureteral stones. The literature also signals 5% hematuria and 13% fever [<xref ref-type="bibr" rid="scirp.131547-ref31">31</xref>] . Complications of renal stones were hydronephrosis (60.9%) and obstructive renal failure (30.4%). That proportion of obstructive renal failure is higher than the ones observed elsewhere: 17.4% [<xref ref-type="bibr" rid="scirp.131547-ref32">32</xref>] , 13.5% [<xref ref-type="bibr" rid="scirp.131547-ref9">9</xref>] . Voiding or storage troubles such as dysuria and pollakiuria were associated with bladder stones. That fact is also observed in several other studies [<xref ref-type="bibr" rid="scirp.131547-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref34">34</xref>] .</p><p>56 patients (74.7%) underwent a surgical treatment: 48 open surgeries (64%) and 8 drainages by pigtail ureteral stent (10.7%). Mini-invasive surgery is not yet introduced into CHUD-BA. Hounnasso et al. apply open surgery to 50.8% cases [<xref ref-type="bibr" rid="scirp.131547-ref16">16</xref>] and Coulibaly et al. perform open surgery in 100% cases [<xref ref-type="bibr" rid="scirp.131547-ref32">32</xref>] .</p><p>We could not evaluate the expulsion rate of ureteral stone treated with alpha-blocker. Yet the efficacy of alpha-blockers as a medical expulsive therapy for ureteral stones have been demonstrated [<xref ref-type="bibr" rid="scirp.131547-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.131547-ref37">37</xref>] .</p></sec><sec id="s6"><title>6. Conclusion</title><p>The prevalence of urinary stone disease was 1.7% at CHUD-BA, northern Benin in 2023. There was a masculine predominance: the sex ratio was 2.75. The patients’ mean age was 41 years. Computed tomography was available, but its high cost hindered its usage. Open surgery was the only treatment tool available.</p></sec><sec id="s7"><title>Limitations</title><p>Some medical records were not available, some other were incomplete. Infrared cristallography or other tool being unavailable, it was impossible to determine the chemical composition of the urinary stones collected after their surgical removal.</p></sec><sec id="s8"><title>Ethical Considerations</title><p>The Ethics Committee in CHUD-BA had authorized the study to be performed.</p></sec><sec id="s9"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s10"><title>Cite this paper</title><p>Isidore, G., Jean, S., Rafiou, T.S., Emmanuel, D., Alexandre, A. and Georges, A.D.J. (2024) Epidemiologic, Diagnostic, and Therapeutic Features of Urinary Stone Disease in Northern Benin from 2018 to 2023. Open Journal of Urology, 14, 128-137. https://doi.org/10.4236/oju.2024.142013</p></sec></body><back><ref-list><title>References</title><ref id="scirp.131547-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Daudron, M., Jungers, P. and Traxer, O. (2012) Lithiase urinaire. Lavoisier, Paris, 691 p.</mixed-citation></ref><ref id="scirp.131547-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Turney, B.W., Appleby, P.N., Reynard, J.M., Noble, J.G., Key, T.G. and Allen, N.E. (2014) Diet and Risk of Kidney Stones in the Oxford Cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). European Journal of Epidemiology, 29, 363-369. https://doi.org/10.1007/s10654-014-9904-5</mixed-citation></ref><ref id="scirp.131547-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Kamina, P. (2022) L’essentiel en anatomie. 4&lt;sup&gt;ème&lt;/sup&gt; Edition, Editions Maloine-23, rue de l’Ecole-de-Médecine, Paris, 381 p. (Atlas d’anatomie)</mixed-citation></ref><ref id="scirp.131547-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Netter, F. (2015) Atlas d’anatomie humaine. 6&lt;sup&gt;ème&lt;/sup&gt; edition, Issy-les-Moulineaux, Elsevier Masson, Amsterdam, 624 p.</mixed-citation></ref><ref id="scirp.131547-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Sorokin, I., Mamoulakis, C., Miyazawa, K., Rodgers, A., Talati, J. and Lotan, Y. (2017) Epidemiology of Stone Disease across the World. World Journal of Urology, 35, 1301-1320. https://doi.org/10.1007/s00345-017-2008-6</mixed-citation></ref><ref id="scirp.131547-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Kaboré, F.A., Kambou, T., Zango, B., Ouattara, A., Simporé, M., Lougué-Sorgho, C., et al. (2013) épidémiologie d’une cohorte de 450 lithiases urinaires au CHU Yalgado Ouédraogo de Ouagadougou (Burkina Faso). Progrès en Urologie, 23, 971-976. https://doi.org/10.1016/j.purol.2013.04.014</mixed-citation></ref><ref id="scirp.131547-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Popkin, B. (2006) Global Nutrition Dynamics: The World Is Shifting Rapidly toward a Diet Linked with Non-Communicable Diseases. The American Journal of Clinical Nutrition, 11, 289-298. https://doi.org/10.1093/ajcn/84.2.289</mixed-citation></ref><ref id="scirp.131547-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Raheem, O.A., Khandwala, Y.S., Sur, R.L., Ghani, K.R. and Denstedt, J.D. (2017) Burden of Urolithiasis: Trends in Prevalence, Treatment, and Costs. European Urology Focus, 3, 18-26. https://doi.org/10.1016/j.euf.2017.04.001</mixed-citation></ref><ref id="scirp.131547-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, Y., Kouka, S.C., Kane, R., Dia, A.A., Charata, Z., Ndiaye, A., et al. (2015) Lithiase du haut appareil urinaire: Aspects épidémiologiques, cliniques, et thérapeutiques dans la région de Thiès, Sénégal. Rmm, 5, 520-525.</mixed-citation></ref><ref id="scirp.131547-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kanno, T., Kubota, M., Sakamoto, H., Nishiyama, R., Okada, T., Higashi, Y., et al. (2014) Determining the Efficacy of Ultrasonography for the Detection of Ureteral Stone. Urology, 84, 533-537. https://doi.org/10.1016/j.urology.2014.04.047</mixed-citation></ref><ref id="scirp.131547-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Dhar, M. and Denstedt, J.D. (2009) Imaging in Diagnosis, Treatment, and Follow-Up of Stone Patients. Advances in Chronic Kidney Disease, 16, 39-47. https://doi.org/10.1053/j.ackd.2008.10.005</mixed-citation></ref><ref id="scirp.131547-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Masch, W.R., Cronin, K.C., Sahani, D.V. and Kambadakone, A. (2017) Imaging in Urolithiasis. Radiologic Clinics of North America, 55, 209-224. https://doi.org/10.1016/j.rcl.2016.10.002</mixed-citation></ref><ref id="scirp.131547-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Degueurce, Y., Kourilsky, O. and Chrétien, Y. (1990) Lithiases phosphocalciques, oxaliques, uriques. In: Impact Internat Néphro-Urologie, Edinter, Paris, 59-66.</mixed-citation></ref><ref id="scirp.131547-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Saklayen, M.G. (1997) Medical Management of Nephrolithiasis. Medical Clinics of North America, 81, 785-799. https://doi.org/10.1016/S0025-7125(05)70546-0</mixed-citation></ref><ref id="scirp.131547-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sossa, J. and Avakoudjo, D.J.G. (2021) The Chemical Composition of Urinary Stones at the Military Teaching Hospital of Cotonou. SAS Journal of Surgery, 7, 549-552. https://doi.org/10.36347/sasjs.2021.v07i10.005</mixed-citation></ref><ref id="scirp.131547-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Hounnasso, P.P., Avakoudjo, J.D.G., Paré, A.K., Brahima, K., Ouattara, A., Agounkpé, M.M., et al. (2015) Symptomatic Urinary Lithiasis: Epidemiology and Management at Urology Department of University Hospital of Cotonou. OJU, 5, 7-12. https://doi.org/10.4236/oju.2015.52002</mixed-citation></ref><ref id="scirp.131547-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Mbouche, L.O., Mbassi, A.A., Eloundou, J.C.N., Aabe, J.A., Kamga, J., Fouda, P.J., et al. (2023) Epidémiologie et diagnostic de la lithiase urinaire: étude transversale dans une population camerounaise. The Pan African Medical Journal, 45, Article No. 61. https://www.panafrican-med-journal.com/content/article/45/61/fullhttps://doi.org/10.11604/pamj.2023.45.61.38677</mixed-citation></ref><ref id="scirp.131547-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Daudon, M. (2000) L’analyse morphoconstitutionnelle des calculs dans le diagnostic étiologique d’une lithiase urinaire de l’enfant. Archives de Pédiatrie, 7, 855-865. https://doi.org/10.1016/S0929-693X(00)80197-9</mixed-citation></ref><ref id="scirp.131547-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Alaya, A., Belgith, M., Jouini, R., Nouri, A. and Najjar, M.F. (2006) La lithiase urinaire de l’enfant en Tunisie. Aspects actuels à propos de 104 cas. Progrès en Urologie, 16, 16474-16480.</mixed-citation></ref><ref id="scirp.131547-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Traxer, O., Lechevallier, E. and Saussine, C. (2008) Lithiase urinaire de l’enfant. Progrès en Urologie, 18, 1005-1014. https://doi.org/10.1016/j.purol.2008.09.037</mixed-citation></ref><ref id="scirp.131547-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Mohammed, S., Yohannes, B., Tegegne, A. and Abebe, K. (2020) Urolithiasis: Presentantion and Surgical Outcome at a Tertiary Care Hospital in Ethiopia. RRU, 12, 623-631. https://doi.org/10.2147/RRU.S284706</mixed-citation></ref><ref id="scirp.131547-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Kaaroud, H., Harzallah, A., Sayhi, M., Bacha, M., Khadhar, M., Goucha, R., et al. (2019) Lithiase urinaire héréditaire: Expérience d’un service de néphrologie. Progrès en Urologie, 29, 962-973. https://doi.org/10.1016/j.purol.2019.08.262</mixed-citation></ref><ref id="scirp.131547-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Kaulanjan, K., Cerruti, A., Galantine, V., Laine, C., Rose, Dite, Modestine, J., Gourtaud, G., et al. (2018) épidémiologie de la lithiase urinaire aux Antilles Fran&amp;#231;aises: étude rétrospective. Progrès en Urologie, 28, 114-119. https://doi.org/10.1016/j.purol.2017.10.005</mixed-citation></ref><ref id="scirp.131547-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Panthier, F., Kaulanjan, K. and Traxer, O. (2023) Livret pour l’interne. Lithiase urinaire. https://www.urofrance.org/wp-content/uploads/2023/06/Lithiase-urinaire.pdf</mixed-citation></ref><ref id="scirp.131547-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Urofrance. Recommandations de bonne pratique pour la prise en charge des calculs et de la lithiase urinaires: Diagnostic, traitement, suivi et prévention secondaire. https://www.urofrance.org/recommandation/recommandations-de-bonne-pratique-pour-la-prise-en-charge-des-calculs-et-de-la-lithiase-urinaires-diagnostic-traitement-suici-et-prevention-secondaire-synthese/</mixed-citation></ref><ref id="scirp.131547-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Bah, I., Baldé, S., Sow, K.B. and Guirassy, S. (2009) La lithiase du bas appareil urinaire: Analyse rétrospective de 111cas au CHU de Conakry. African Journal of Urology, 15, 38-43. https://doi.org/10.1007/s12301-009-0008-5</mixed-citation></ref><ref id="scirp.131547-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Saussine, C., Lechevallier, E. and Traxer, O. (2008) Calculs et anomalies urétérales. Progrès en Urologie, 18, 997-999. https://doi.org/10.1016/j.purol.2008.09.001</mixed-citation></ref><ref id="scirp.131547-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Cochat, P., Bacchetta, J., Sabot, J.F., Bertholet-Thomas, A. and Demède, D. (2012) Lithiase urinaire de l’enfant. Journal de Pédiatrie et de Puériculture, 25, 255-268. https://doi.org/10.1016/j.jpp.2012.07.008</mixed-citation></ref><ref id="scirp.131547-ref29"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abago</surname><given-names> B. </given-names></name>,<etal>et al</etal>. (<year>2021</year>)<article-title>Lithiase urinaire: Aspects épidémiologiques, cliniques et thérapeutiques au Centre Hospitalier Universitaire Sylvanus Olympio de Lomé</article-title><source> Revue Africaine de Médecine Interne</source><volume> 8</volume>,<fpage> 31</fpage>-<lpage>38</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.131547-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Coulibaly, Y., Ouattara, Z., Togo, A., Konaté, M., Ouattara, M. and Ouattara, K. (2011) Bilharziose urinaire et lithogenèse: étude de 23 cas au CHU Gabriel Touré. Mali Médical, 26, 26-28.</mixed-citation></ref><ref id="scirp.131547-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Loumingou, R., Eyeni, T. and Gassongo-Koumou, G. (2019) La lithiase rénale au CHU de Brazzaville: Aspects métaboliques et nutritionnels à l’Université de Brazzaville. Annales des Sciences de la Santé, 19, 46-52.</mixed-citation></ref><ref id="scirp.131547-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Coulibaly, I. (2014) Lithiase urétérale: Aspects cliniques, démarche diagnostique et thérapeutique dans le Service d’Urologie du CHU Gabriel Touré du Mali. https://www.bibliosante.ml/handle/123456789/734</mixed-citation></ref><ref id="scirp.131547-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Abarchi, H., Hachem, A., Erraji, M., Belkacem, R., Outarahout, N. and Barahioui, M. (2003) Lithiase vésicale de l’enfant: à propos de 70 cas. Annales d’Urologie (Paris), 37, 117-119. https://doi.org/10.1016/S0003-4401(03)00051-2</mixed-citation></ref><ref id="scirp.131547-ref34"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Odzebe</surname><given-names> A.S.W. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>Chirurgie à ciel ouvert de la lithiase urinaire au CHU de Brazzaville: Analyse de 68 cas</article-title><source> Mali Médical</source><volume> 25</volume>,<fpage> 32</fpage>-<lpage>35</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.131547-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Ziaeefar, P., Basiri, A., Zangiabadian, M., de la Rosette, J., Zargar, H., Taheri, M., et al. (2023) Medical Expulsive Therapy for Pediatric Ureteral Stones: A Metanalysis of Randomized Clinical Trials. Journal of Clinical Medicine, 12, Article No. 1410. https://doi.org/10.3390/jcm12041410</mixed-citation></ref><ref id="scirp.131547-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Campschroer, T., Zhu, Y., Duijvesz, D., Grobbee, D.E. and Lock, M.T.W.T. (2014) Alpha-Blockers as Medical Expulsive Therapy for Ureteral Stones. Cochrane Database of Systematic Reviews, 4, CD008509. https://doi.org/10.1002/14651858.CD008509.pub2</mixed-citation></ref><ref id="scirp.131547-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Liu, X.J., Wen, J.G., Wan, Y.D., Hu, B.W., Wang, Q.W. and Wang, Y. (2018) Role of Medical Expulsive Therapy in Ureteral Calculi: A Meta-Analysis of Randomized Controlled Trials. Urolithiasis, 46, 211-218. https://doi.org/10.1007/s00240-017-0974-1</mixed-citation></ref></ref-list></back></article>